Sign In
Home
About Us
Benefits
Pricing
Krixos Global Intel
Krixos
Contact Us
Breaking Cancer News A-Z
Health/Pharma Companies
Drugs, Treatments, Trials
Hot Topics
Clinical Trials - Latest News
Other Illnesses & Conditions
Latest Healthcare News
My Settings
Client Requests
Advanced Search
My Viewed Articles
All Cancer News
Acute Lymphoblastic Leukemia
Acute myeloid leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adrenocortical Carcinoma
Anal Cancer
Anaplastic Astrocytoma
Angiosarcoma
Astrocytoma
Basal-Cell Carcinoma
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer Cachexia
Carcinoma
Cervical Cancer
Childhood Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Adenocarcinoma
Colorectal Cancer
Craniopharyngioma
Endometrial Cancer
Ependymoma
Esophageal Cancer
Ewing's Sarcoma
Gallbladder Cancer
Germ Cell Tumors
Glioblastoma
Glioma
Hairy Cell Leukemia
Hepatocellular Carcinoma
Hodgkin Lymphoma
Kaposi's Sarcoma
Kidney & Renal Cancer
Laryngeal Cancer
Leukemia
Liver Cancer
Lung Adenocarcinoma
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MCRPC
Medulloblastoma
Melanoma
Meningioma
Mesothelioma
Metastatic Colon Cancer
Mouth Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Myelofibrosis
Nasopharyngeal Carcinoma
Neuroblastoma
NMIBC
Non-Hodgkin Lymphoma
NSCLC
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Penile Cancer
Pheochromocytoma
Prostate Cancer
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Sarcopenia
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Stomach (Gastric) Cancer
Synovial Sarcoma
Testicular Cancer
Thymic Carcinoma
Thymoma
Thyroid Cancer
Tongue Cancer
Uterine Cancer
Vulvar Cancer
Waldenstrom Macroglobulinemia
You need to login...
Enter your email:
Enter your password:
If you are not registered...
Subscribe to Krixos Health:
Sign Up Now:
Your email:
or call us on: +43 (0)1 27 63 015
or email:
subscribe@krixos.com
Most viewed
1.
TFS HealthScience Expands Collaboration with Oncomatryx for Phase Ib Trial of OMTX705 for Pancreatic Cancer
2.
Repurposing riluzole as an anti-osteosarcoma agent
3.
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
4.
Nanobiotix presents outcomes from trial of JNJ-1900 for pancreatic cancer
5.
Biologists identify targets for new pancreatic cancer treatments
6.
Study reveals how lysosomal iron drives ferroptosis to kill resistant cancer cells
7.
Incidence rates of some cancer types have risen in people under age 50
8.
Drug trial offers hope for patients with hard-to-treat lung cancer in China, US
9.
Worried About Prostate Cancer Screening? New Study Shows Better Judgment In Treatment
10.
Incidence rates of some cancer types have risen in people under age 50
Last updated at 4:03 GMT
Hot News Makers
Health/Pharma Companies
Sentara Healthcare
12301.24
Rabin Medical Center
4219.81
HIMSS
2960.82
Dignitas
1261.39
Clalit Health
498.74
GoodRx
450.68
Children's Tumor Foundation
316.59
Royal College of Midwives
269.69
Poseida Therapeutics
148.38
Sheba Medical Center
110.14
Drugs, Treatments, Trials
Lenalidomide
0.11
Last updated at 3:10 GMT